• Health & Medicine

Living with a brain tumour – Sue’s story

Brain tumour research is one of our top priorities. Here, Sue shares her experience of living with an incurable brain tumour. Brain tumour research is one of our top priorities. Here, Sue shares her experience of living with an incurable brain tumour.

3 August 2018

• Health & Medicine

My brain tumour treatment journey – Parminder’s story

Brain tumour research is one of our top priorities. Here, Parminder takes us through her treatment journey after she was diagnosed with an astrocytoma. Brain tumour research is one of our top priorities. Here, Parminder takes us through her treatment journey after she was diagnosed with an astrocytoma.

1 August 2018

• Science & Technology
• Health & Medicine

Piecing together brain tumour biology to design more effective drugs

Scientists are slowly uncovering what makes brain tumours tick. Combining this information with research on the healthy brain could lead to new treatments. Scientists are slowly uncovering what makes brain tumours tick. Combining this information with research on the healthy brain could lead to new treatments.

31 July 2018

• Health & Medicine

Immunotherapy drug made available for some NHS patients with Hodgkin lymphoma

The immunotherapy drug pembrolizumab (Keytruda) can now be used to treat some patients with Hodgkin lymphoma on the NHS in England. The immunotherapy drug pembrolizumab (Keytruda) can now be used to treat some patients with Hodgkin lymphoma on the NHS in England.

27 July 2018

• Health & Medicine

Mixing complementary therapy with standard cancer treatment could affect survival

A new study explores the impact that mixing complementary therapy with conventional cancer treatment can have on survival. A new study explores the impact that mixing complementary therapy with conventional cancer treatment can have on survival.

20 July 2018

• Health & Medicine

Older people and cancer: how research could personalise treatment plans and care

We look at how research could help to adapt and improve treatment for older patients, including inclusive clinical trials and pre-habilitation. We look at how research could help to adapt and improve treatment for older patients, including inclusive clinical trials and pre-habilitation.

16 July 2018

• Health & Medicine

Brain tumour chemotherapy now available to even more NHS patients

Thanks to a trial we supported, people with a type of brain tumour now have a new treatment option – a chemotherapy we developed. Thanks to a trial we supported, people with a type of brain tumour now have a new treatment option – a chemotherapy we developed.

11 July 2018

• Health & Medicine

Drug could protect children from hearing loss after chemo

New trials results show that a drug can reduce hearing loss in children treated with the chemo drug cisplatin. New trials results show that a drug can reduce hearing loss in children treated with the chemo drug cisplatin.

20 June 2018

• Health & Medicine

New drug halves hearing loss in children following cancer treatment

Giving the drug sodium thiosulphate after chemotherapy reduces hearing loss in children treated for liver cancer, according to new research. Giving the drug sodium thiosulphate after chemotherapy reduces hearing loss in children treated for liver cancer, according to new research.

20 June 2018

• Health & Medicine

‘Our NHS is there for us, now it’s time to stand with them’

We've launched a campaign for more NHS staff to diagnose and treat cancer. Cancer survivor Elizabeth Bailey explains how you can get involved. We've launched a campaign for more NHS staff to diagnose and treat cancer. Cancer survivor Elizabeth Bailey explains how you can get involved.

15 June 2018

• Health & Medicine

Cancer Research UK tests first of its kind vaccine to treat lung cancer

A first of its kind treatment vaccine has moved into a phase I clinical trial for patients with non-small cell lung cancer. A first of its kind treatment vaccine has moved into a phase I clinical trial for patients with non-small cell lung cancer.

12 June 2018

• Health & Medicine

Prostate cancer drug given initial ‘no’ for NHS in England

The prostate cancer drug abiraterone has been provisionally rejected as a first-line treatment on the NHS in England. The prostate cancer drug abiraterone has been provisionally rejected as a first-line treatment on the NHS in England.

7 June 2018